- Protein Microarrays
- Spectroscopy
- X-ray Crystallography
- Chromatography
- Electrophoresis
- Surface Plasmon Resonance
Proteomics Market size was valued at USD 20,869.2 million in 2022 and is poised to grow at a CAGR of 12.5% from 2023-29. Proteomics is a technique for identifying and studying proteins implicated in diseases, as well as their expression, activity, and structure. Proteomic research may also be utilized to find prognostic indicators and diagnose cancer, infectious illnesses, malaria, and TB. In the pharmaceutical sector, proteomics is utilized to examine the mechanism of medication action or toxicity. Based on the technology protein microarray segment generated the highest revenue in 2021 in the proteomics market, owing to the technology being widely used to track protein interactions in less time than other technologies. Furthermore, this procedure requires less time and is cost-effective. The entire information about DNA/RNA binding proteins can be made available with the use of a protein microarray. Moreover, based on components, the reagents segment accounted for the majority of proteomics market share, it is attributed to the availability of a wide range of reagents and the need for reliable, specific, and fast detection of diseases at the early stages as they are extensively utilized in primary screening in drug discovery and microarray technologies. Increasing demand for factors like rising demand for personalized medicine, increasing R&D expenditure, government funding for proteomics, and technological advancements driving the market growth over the forecast years
Proteomics Market Key Developments:
- In Feb 2021, Agilent Technologies Inc. launched Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
Global Proteomics Market Summary
Study Period
2023-29
Base Year
2022
CAGR
0.125%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Proteomics Market Dynamics
The market is expected to offer lucrative opportunities due to increase research and development programs and increase biotech expenditure attributing to coronavirus driving the global proteomic market growth. Moreover, due to technological advancement, increase in research funding, growing healthcare spending, demand for customized medicine, and rise in the prevalence of genetic diseases also immense boost to the market over the forecast years.
North-America Got Significant Share of
Proteomics Market Regional Analysis
North America has the largest share in the global proteomics market and the market is expected to grow at a significant CAGR over the forecast years owing to increasing investments in personalized medicine, the existence of global market leaders, increased research in the disciplines of omics, and increased investments in structure-based drug design. Moreover, Asia Pacific is also likely to show significant growth over the forecasting period owing to rise in prevalence of genetic disease, increase in R&D expenditure, and expansion of business by the market players into the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Proteomics Market Segmentation
By Technology
By Component
- Reagents & Kits
- Instruments
- Software & Services
By Application
- Research Applications
- Clinical Applications
By End User
- Pharmaceutical & Biotechnology
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Frequently Asked Questions
The CAGR of the proteomics market is 12.5% over the forecast period (2023 - 2029)
Thermo Fisher Scientific, Agilent Technologies, Bruker Corporation, Bio-Rad Laboratories, PerkinElmer
The Asia Pacific is the fastest-growing region for the proteomics market
| 1. Executive Summary |
| 2. Global Proteomics Market Introduction |
| 2.1.Global Proteomics Market - Taxonomy |
| 2.2.Global Proteomics Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Component |
| 2.2.3.Application |
| 2.2.4.Region |
| 3. Global Proteomics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Proteomics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Proteomics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Protein Microarrays |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Spectroscopy |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. X-ray Crystallography |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Chromatography |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Electrophoresis |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Surface Plasmon Resonance |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Proteomics Market By Component, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Reagents & Kits |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Instruments |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Software & Services |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Proteomics Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Research Applications |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinical Applications |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Proteomics Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Proteomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Protein Microarrays |
| 9.1.2.Spectroscopy |
| 9.1.3.X-ray Crystallography |
| 9.1.4.Chromatography |
| 9.1.5.Electrophoresis |
| 9.1.6.Surface Plasmon Resonance |
| 9.2. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Reagents & Kits |
| 9.2.2.Instruments |
| 9.2.3.Software & Services |
| 9.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Research Applications |
| 9.3.2.Clinical Applications |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Proteomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Protein Microarrays |
| 10.1.2.Spectroscopy |
| 10.1.3.X-ray Crystallography |
| 10.1.4.Chromatography |
| 10.1.5.Electrophoresis |
| 10.1.6.Surface Plasmon Resonance |
| 10.2. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Reagents & Kits |
| 10.2.2.Instruments |
| 10.2.3.Software & Services |
| 10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Research Applications |
| 10.3.2.Clinical Applications |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11. Asia Pacific (APAC) Proteomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Protein Microarrays |
| 11.1.2.Spectroscopy |
| 11.1.3.X-ray Crystallography |
| 11.1.4.Chromatography |
| 11.1.5.Electrophoresis |
| 11.1.6.Surface Plasmon Resonance |
| 11.2. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Reagents & Kits |
| 11.2.2.Instruments |
| 11.2.3.Software & Services |
| 11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Research Applications |
| 11.3.2.Clinical Applications |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Proteomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Protein Microarrays |
| 12.1.2.Spectroscopy |
| 12.1.3.X-ray Crystallography |
| 12.1.4.Chromatography |
| 12.1.5.Electrophoresis |
| 12.1.6.Surface Plasmon Resonance |
| 12.2. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Reagents & Kits |
| 12.2.2.Instruments |
| 12.2.3.Software & Services |
| 12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Research Applications |
| 12.3.2.Clinical Applications |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Proteomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Protein Microarrays |
| 13.1.2.Spectroscopy |
| 13.1.3.X-ray Crystallography |
| 13.1.4.Chromatography |
| 13.1.5.Electrophoresis |
| 13.1.6.Surface Plasmon Resonance |
| 13.2. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Reagents & Kits |
| 13.2.2.Instruments |
| 13.2.3.Software & Services |
| 13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Research Applications |
| 13.3.2.Clinical Applications |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Agilent Technologies, Inc. |
| 14.2.2.Bio-Rad Laboratories, Inc. |
| 14.2.3.Bruker Corporation |
| 14.2.4.Danaher Corporation |
| 14.2.5.GE Healthcare |
| 14.2.6.Merck KGaA |
| 14.2.7.Promega Corporation |
| 14.2.8.Thermo Fisher Scientific, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- GE Healthcare
- Merck KGaA
- Promega Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation